A Multi-center Study to Evaluate the Pharmacokinetics ofDiacerein and Rhein and the Safety of Diacerein after MaximumUse, Topical Administration of CCP-020 (Diacerein 1%ointment) to Patients with Epidermolysis Bullosa (EB)

Project: Research project

Description

A Multi-center Study to Evaluate the Pharmacokinetics of Diacerein and Rhein and the Safety of Diacerein after Maximum Use, Topical Administration of CCP-020 (Diacerein 1% ointment) to Patients with Epidermolysis Bullosa (EB)
StatusFinished
Effective start/end date1/21/197/31/19

Funding

  • CASTLE CREEK PHARMACEUTICALS, LLC

Fingerprint

diacetylrhein
Epidermolysis Bullosa
Topical Administration
Ointments
Pharmacokinetics
Safety
rhein